Biocompatibility of folate-modified chitosan nanoparticles

Asian Pacific Journal of Tropical Biomedicine

Volumn 2, Issue 3, 2012, Pages 215-219

  Chakraborty, Subhankari Prasad ^a   Sahu, Sumanta Kumar ^b   Pramanik, Panchanan ^b   Roy, Somenath ^a  

^a VIDYASAGAR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Carboxymethyl chitosan; Folate; Killing kinetic studies; MTT assay; Staphylococcus aureus

Indexed keywords

CARBOXYMETHYL CHITOSAN 2,2' ETHYLENEDIOXY BIS ETHYLAMINE FOLATE; CHITOSAN DERIVATIVE; NANOPARTICLE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; CARBOXYMETHYL-CHITOSAN; CHITOSAN; ETHYLAMINE; FOLIC ACID;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BIOCOMPATIBILITY; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; COVALENT BOND; DISK DIFFUSION; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; LINKAGE ANALYSIS; MALE; MICROBIAL GROWTH; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NANOANALYSIS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TOXICITY TESTING; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HUMAN; MATERIALS TESTING; MICROBIAL SENSITIVITY TEST; TOXICITY;

STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; CHITOSAN; ETHYLAMINES; FOLIC ACID; HELA CELLS; HUMANS; MALE; MATERIALS TESTING; MICE; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 84858137310     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60044-6     Document Type: Article

References (14)

1. Chakraborty SP, Mahapatra SK, Sahu SK, Chattopadhyay S, Pramanik P, Roy S. Nitric oxide mediated Staphylococcus aureus pathogenesis and protective role of nanoconjugated vancomycin. Asian Pac J Trop Biomed 2011; 1(2): 105-112.
2. Espinosa-Garci{dotless}a BM, Arguelles-Monal WM, Hernandez J, Valenzuela LF, Acosta N, Goycoolea FM. Molecularly imprinted chitosan-genipin hydrogels with recognition capacity toward o-xylene. Biomacromolecules 2007; 8: 3355-3364.
3. Liu TY, Chen S, Lin Y, Liu D. Synthesis and characterization of amphiphatic carboxymethyl-hexanoyl chitosan hydrogel: waterretention ability and drug encapsulation. Langmuir 2006; 22: 9740-9745.
4. Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym 2008; 73: 44-54.
5. Turan K, Nagata K. Chitosan-DNA nanoparticles: the effect of cell type and hydrolysis of chitosan on in vitro DNA transfection. Pharm Dev Technol 2006; 11: 503-512.
6. Chakraborty SP, Sahu SK, Mahapatra SK, Santra S, Bal M, Roy S, et al. Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents. Nanotechnology 2010; 21: 105103.
7. Chakraborty SP, Mahapatra SK, Sahu SK, Pramanik P, Roy S. Antioxidative effect of folate-modified chitosan nanoparticles. Asian Pac J Trop Biomed 2011; 1(1): 29-38.
8. Chakraborty SP, Mahapatra SK, Bal M, Roy S. Isolation and identification of vancomycin resistant Staphylococcus aureus from post operative pus sample. Al Ameen J Med Sci 2011; 4(2): 152-168.
9. Ecobichon DJ. The basis of toxicology testing. New York: CRC Press; 1997, p. 43-86.
10. Chakraborty SP, Mahapatra SK, Roy S. Biochemical characters and antibiotic susceptibility of Staphylococcus aureus isolates. Asian Pac J Trop Biomed 2011; 1(3): 192-196.
11. Acar JF, Goldstain FW. The disc susceptibility test. In: Lorian V. (ed.) Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins; 1980, p. 24-25.
12. Bauer AW, Kirby WMM, Sherris JC, Turch M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493-496.
13. Yang XY, Li CR, Lou RH, Wang YM, Zhang WX, Chen HZ, et al. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China. J Med Microbiol 2007; 56: 71-76.
14. OECD. OECD guidelines for the testing of chemicals test No. 423: acute oral toxicity-acute toxic class method. OECD; 1996.